1. Home
  2. SXTP vs VTAK Comparison

SXTP vs VTAK Comparison

Compare SXTP & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXTP
  • VTAK
  • Stock Information
  • Founded
  • SXTP 2010
  • VTAK 2002
  • Country
  • SXTP United States
  • VTAK United States
  • Employees
  • SXTP N/A
  • VTAK N/A
  • Industry
  • SXTP Biotechnology: Pharmaceutical Preparations
  • VTAK Medical/Dental Instruments
  • Sector
  • SXTP Health Care
  • VTAK Health Care
  • Exchange
  • SXTP Nasdaq
  • VTAK Nasdaq
  • Market Cap
  • SXTP 2.7M
  • VTAK N/A
  • IPO Year
  • SXTP 2023
  • VTAK 2018
  • Fundamental
  • Price
  • SXTP $2.26
  • VTAK $0.26
  • Analyst Decision
  • SXTP Hold
  • VTAK
  • Analyst Count
  • SXTP 1
  • VTAK 0
  • Target Price
  • SXTP N/A
  • VTAK N/A
  • AVG Volume (30 Days)
  • SXTP 457.4K
  • VTAK 236.4K
  • Earning Date
  • SXTP 05-19-2025
  • VTAK 05-16-2025
  • Dividend Yield
  • SXTP N/A
  • VTAK N/A
  • EPS Growth
  • SXTP N/A
  • VTAK N/A
  • EPS
  • SXTP N/A
  • VTAK N/A
  • Revenue
  • SXTP $681,345.00
  • VTAK $420,000.00
  • Revenue This Year
  • SXTP $95.50
  • VTAK $822.86
  • Revenue Next Year
  • SXTP $80.78
  • VTAK $168.42
  • P/E Ratio
  • SXTP N/A
  • VTAK N/A
  • Revenue Growth
  • SXTP 168.70
  • VTAK N/A
  • 52 Week Low
  • SXTP $1.41
  • VTAK $0.24
  • 52 Week High
  • SXTP $36.00
  • VTAK $8.40
  • Technical
  • Relative Strength Index (RSI)
  • SXTP 43.50
  • VTAK 36.28
  • Support Level
  • SXTP $2.21
  • VTAK $0.27
  • Resistance Level
  • SXTP $2.45
  • VTAK $0.39
  • Average True Range (ATR)
  • SXTP 0.44
  • VTAK 0.03
  • MACD
  • SXTP -0.09
  • VTAK -0.00
  • Stochastic Oscillator
  • SXTP 6.86
  • VTAK 0.00

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.

Share on Social Networks: